This illustration provided by AstraZeneca depicts packaging for their medication Beyfortus. U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year. The Food and Drug Administration on Monday, July 17, 2023 approved the injection for infants and children up to 2 years old. (AstraZeneca via AP)
By Matthew Perrone
U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.
“Today’s approval addresses the great need for products to help reduce the impact of RSV disease on children, families and the health care system” said FDA's Dr. John Farley in a statement.
Last year, a surge in RSV cases flooded U.S. hospitals with wheezing children. There are no vaccines for babies yet, though Pfizer and other companies are working on them.
AstraZeneca’s drug, to be sold under the brand name Beyfortus, is a laboratory-made version of an antibody that helps the immune system fight off RSV. Under the FDA approval, babies — including preterm infants — can receive a single injection to protect against their first season of RSV, which typically lasts about five months. Children up to age 2 can receive another dose to protect them during their second season facing the virus.
Beyfortus, which will be marketed in the U.S. by Sanofi, is already approved in Canada, Europe and the U.K. Sanofi did not immediately announce the U.S. price of the treatment.
FDA officials approved the drug based on three studies showing Beyfortus reduced the risk of RSV infection between 70% and 75% among infants and children 2 and younger.
Advisers to the Centers for Disease Control and Prevention will meet early next month to recommend exactly who should get the drug.
A similar antibody drug won FDA approval more than 20 years ago, but it’s only recommended for high-risk babies and requires monthly injections. Pediatricians say the drug is underutilized and they expect the longer-lasting effect of AstraZeneca's shot to improve uptake.
In the U.S., about 58,000 children younger than 5 are hospitalized for RSV each year and several hundred die.
After decades of setbacks for RSV research, drugmakers have made big strides this year, launching the first vaccines against the virus. In May, the FDA approved two RSV vaccines for older adults from GlaxoSmithKline and Pfizer. In August, the FDA is expected to make a decision on approving Pfizer’s vaccine for pregnant women, with the aim of passing along protection to their newborns.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
The 2022 County Health Rankings largely found that the pandemic worsened the burdens faced by women, people of color, and in low income brackets. Cheddar News speaks with Sheri Johnson, co-director of County Health Rankings and Roadmaps who breaks down the details.
With National Infertility Awareness Week underway, the fertility and family-building benefits provider for employers, Kindbody, is looking to make a full suite of treatments and care accessible — including for LGBTQ+ patients. Founder and chairwoman Gina Bartasi joined Cheddar's Opening Bell to talk about the importance of infertility awareness, what role employers play in offering benefits, and how to remove the stigma around the fertility conversation. "We have to talk about the patient holistically, not just fertility services, but what can we do from a mental health standpoint to support patients," she said. "Most patients talk about fertility being more stressful than divorce, infertility being more prevalent than cancer or diabetes. So it is our mission, remains our mission, to elevate awareness around infertility, not just [during] National Infertility Awareness Week."
New York City’s geography makes it particularly at risk to the impacts of climate change - like rising seas and subsequent flooding. The city has already experienced the effects of increasingly severe weather. In response, the city is building a plan to protect itself, from flood walls, to levees, to redesigning its coast.
With mask mandates lifted across various parts of the country, healthy indoor air quality in public spaces is more crucial than ever before. According to the CDC, proper ventilation, in addition to other preventative measures, is instrumental to preventing the rapid spread of covid-19 indoors. As the push for higher air quality ramps up, AtmosAir is providing a high-tech solution for cleaner, greener air indoors. Steve Levine, CEO, AtmosAir, joined Cheddar’s Opening Bell to discuss.
Catching you up on what you need to know on April 27, 2022, with Tesla stocks absorbing an initial hit following Elon Musk's purchase of Twitter, Russia pausing its natural gas supplies to Poland and Bulgaria, NASA's SpaceX Crew-4 mission taking off, and more.
New Mexico is under a state of emergency after flames scorched across 84 square miles. Strong winds fueled 20 wildfires, destroying hundreds of buildings in the state this weekend. New Mexico is just one of several states across the southwest facing severe wildfires. James McMullen, retired California state fire marshal and forensic fire expert, joins Cheddar News to discuss.
SpoonTEK is an eating utensil that uses new technology to enhance flavors. Co-founders Ken and Cameron Davidov join Cheddar News to explain how the high-tech silverware can not only boost taste but also the health of its user.
Tim Brown, research professor at Desert Research Institute and director at the Western Regional Climate Center, joins Cheddar News to discuss the environmental impact of recent wildfires.
Vice President Kamala Harris tested positive for COVID-19 on Tuesday, the White House announced. That's underscoring the persistence of the highly contagious virus even as the U.S. eases restrictions in a bid to revert to pre-pandemic normalcy.
